ArticleBMC cancer2023

Correction to: DNMT3A low-expression is correlated to poor prognosis in childhood B-ALL and confers resistance to daunorubicin on leukemic cells.

Weijing Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.